Marketers have been watching the FTC’s challenge to POM Wonderful’s ad claims with interest. Last year, the United States Court of Appeals for the D.C. Circuit ruled that the company deceptively advertised that the products could treat, prevent, or reduce the risk of heart disease, prostate cancer, and erectile dysfunction. The D.C. Circuit also upheld the Commission’s finding that POM falsely claimed to have clinical proof to support those representations. The latest word on the subject: The Supreme Court just denied the company’s request to review the decision. If it’s been a while since you’ve read the ruling, is it time to take another look at what the D.C. Circuit said about substantiating health claims?